Chulalongkorn University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bangkok Thailand (1914)

Organization Overview

First Clinical Trial
2004
NCT00386646
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anesthesiology Department, Faculty of Medicine, Culalongkorn University. | C2F Chulalongkorn University, Faculty of Medicine, Chulalongkorn University | Center of Excellence in Vaccine Research and Development, Chulalongkorn University | Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University | Chulalongkorn Hospital | Chulalongkorn Universitiy | Chulalongkorn University | Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society | Chulalongkorn University, Bangkok | Chulalongkorn University Faculty of Medicine | Chulalongkorn University, Faculty of Medicine, Department of Obstetrics and Gynecology | Chulalongkorn University, Thailand | Chula Vaccine Research Center (ChulaVRC), Faculty of Medicine, Chulalongkorn University | Culalongkorn University | Department of Medicine at Chulalongkorn University, Bangkok, Thailand | Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital | Department of Medicine, Faculty of Medicine, Chulalongkorn University and Thai Red Cross Aids Research Centre - HIV-NAT | Department of Obstetrics and Bynecology, Faculty of Medicine, Chulalongkorn University | Department of Obstetrics and Gynecology of King Chulalongkorn Memorial Hospital | Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University | Department of Otolaryngology , Faculty of Medicine , Chulalongkorn University | Department of Pediatric , Faculty of Medicine, Chulalongkorn University and Thai Red Cross AIDS Research Centre - HIV-NAT | Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University | Department of Physiology, Faculty of Dentistry, Chulalongkorn University | Division of Hematology and Stem Cell Transplant, Department of Medicine, Faculty of Medicine, Chulalongkorn University | Emergency Unit, Faculty of Medicine, Chulalongkorn Hospital | Excellence Center of Critical Care Nephrology, Chulalongkorn University | Faculty of Medicine, Chulalongkorn University, Bangkok Thailand | Faculty of Pharmaceutical Sciences, Chulalongkorn University | Gastroenterology unit, King Chulalongkorn Memorial Hospital | HIV-NAT and Chulalongkorn University | HIV-NAT, The Thai Red Cross AIDS Research Centre (TRCARC), and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand | Infectious Disease, Chulalongkorn University | King Chulalongkorn Memmorial Hospital | King Chulalongkorn Memorial Hospital | King Chulalongkorn Memorial Hospital and Chulalongkorn University | Menopause unit of Chulalongkorn hospital | Pediatric Gastroenterology Unit,Faculty of Medicine, Chulalongkorn University | Pediatric infectious diseases section, King Chulalongkorn Memorial hospital, Chulalongkorn University | Pediatric infectious diseases unit, Chulalongkorn University | Queen Saovabha Memorial Institute | Queen Saovabha Memorial Institute. Faculty of Medicine, Chulalongkorn university | Queen Saovabha Memorial Institute, Thai Red Cross Society | Roongroj Bhidayasiri

Active Ingredients

Drugs in Phase 4 Trials (66)

alginic acid (1 trial)

aliskiren (tekturna) (1 trial)

aluminum (1 trial)

aluminum hydroxide (Gaviscon) (1 trial)

antihemophilic factor viii human (Hemofil M) (1 trial)

atazanavir (reyataz) (2 trials)

betalin complex (1 trial)

bivalent oral polio vaccine (bopv), type 1 and type 3 (1 trial)

boostrix (1 trial)

cefazolin (ancef) (2 trials)

cefepime (maxipeme) (1 trial)

ceftazidime (fortaz) (2 trials)

celecoxib (celebrex) (1 trial)

cellulose (1 trial)

cinacalcet (sensipar) (1 trial)

cinnarizine (1 trial)

cyclosporine (sandimmune) (2 trials)

desogestrel (Mercilon) (1 trial)

dexmedetomidine (precedex) (1 trial)

diazepam (valium) (1 trial)

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)

drospirenone (Yasmin) (1 trial)

dydrogesterone (gynorest) (3 trials)

emtricitabine (emtriva) (1 trial)

enalapril (vasotec) (3 trials)

ergocalciferol (drisdol) (2 trials)

ethinyl estradiol (Estinyl) (1 trial)

etonogestrel (1 trial)

folic acid (1 trial)

ginger (1 trial)

lamivudine (epivir) (5 trials)

levonorgestrel (1 trial)

lopinavir (Kaletra) (8 trials)

losartan (cozaar) (3 trials)

magnesium hydroxide (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

medroxyprogesterone (provera) (3 trials)

metoclopramide (reglan) (1 trial)

moringa oleifera (1 trial)

mycophenolate (myfortic) (5 trials)

neostigmine (bloxiverz) (1 trial)

nevirapine (viramune) (4 trials)

norgestrel (Ovral) (2 trials)

pantoprazole (protonix) (2 trials)

prednisone (meticorten) (3 trials)

pregabalin (lyrica) (1 trial)

propofol (diprivan) (1 trial)

quinvaxem (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

ritonavir (Norvir) (8 trials)

rituximab (rituxan) (1 trial)

rocuronium (zemuron) (1 trial)

rotigotine (neupro) (1 trial)

scopolamine (transderm scop) (1 trial)

sodium chloride (3 trials)

sodium citrate (2 trials)

soy protein (1 trial)

stavudine (zerit) (1 trial)

sugammadex (bridion) (1 trial)

tenofovir (viread) (4 trials)

testosterone (delatestryl) (2 trials)

verorab (1 trial)

vitamin d3 (3 trials)

vzv vaccine (1 trial)

whey protein (1 trial)

zidovudine (retrovir) (3 trials)

Drugs in Phase 3 Trials (30)

abacavir (ziagen) (2 trials)

acetaminophen (tylenol) (1 trial)

bevacizumab (avastin) (1 trial)

cyclophosphamide (cytoxan) (3 trials)

efavirenz (sustiva) (3 trials)

elbasvir (1 trial)

epidermal growth factor (1 trial)

essential oils (1 trial)

estrogen (1 trial)

gabapentin (neurontin) (1 trial)

ganciclovir (cytovene) (1 trial)

gramicidin d (1 trial)

grazoprevir (zepatier) (1 trial)

iron (1 trial)

isoniazid (nydrazid) (1 trial)

ketoconazole (nizoral) (1 trial)

ketosteril (1 trial)

nelfinavir (viracept) (1 trial)

neomycin (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

probiotic (2 trials)

repamipide (1 trial)

rifapentine (priftin) (1 trial)

ringer's lactate (1 trial)

silver sulfadiazine (silvadene) (1 trial)

teriparatide (1 trial)

tinospora (1 trial)

urea (1 trial)

valganciclovir (valcyte) (1 trial)

zingiber cassumunar roxb. extract (1 trial)

Drugs in Phase 2 Trials (15)

alemtuzumab (campath) (1 trial)

azd1222 (1 trial)

bnt162b2 (1 trial)

brentuximab vedotin (adcetris) (1 trial)

dolutegravir (tivicay) (2 trials)

doxorubicin (Doxil) (1 trial)

estradiol (progynon depot) (1 trial)

gemcitabine (gemzar) (1 trial)

ibritumomab tiuxetan (zevalin) (1 trial)

lidocaine (xylocaine) (1 trial)

methotrexate (1 trial)

raltegravir (isentress) (1 trial)

rifabutin (mycobutin) (1 trial)

sorafenib (nexavar) (1 trial)

vincristine (oncovin) (1 trial)

Drugs in Phase 1 Trials (6)

curcumin (1 trial)

glutathione (1 trial)

hivis dna vaccine (1 trial)

hpv 16/18 vaccine (Cervarix) (2 trials)

lime powder (1 trial)

mva-cmdr (1 trial)

Drugs in Other Trials (48)

99mtc-mibi (1 trial)

antirabies serum (equine) (1 trial)

astaxanthin (1 trial)

atorvastatin (lipitor) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

calcium (1 trial)

calcium carbonate (1 trial)

ciprofloxacin (cipro) (1 trial)

clarithromycin (biaxin) (1 trial)

clindamycin (cleocin) (1 trial)

cumin (1 trial)

dapsone (aczone) (1 trial)

dexamethasone (1 trial)

diclofenac (voltaren) (1 trial)

Dimocarpus longan (4 trials)

dopamine (intropin) (1 trial)

doxycycline (vibramycin) (1 trial)

entecavir (baraclude) (1 trial)

epinephrine (levophed) (1 trial)

everolimus (zortress) (3 trials)

furosemide (lasix) (1 trial)

gentamicin (garamycin) (1 trial)

ginger extract (1 trial)

glucose (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

inactivated influenza vaccine (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

inulin (1 trial)

leflunomide (arava) (1 trial)

lingzhi (1 trial)

live attenuated chimeric japanese encephalitis vaccine (1 trial)

loceryl (1 trial)

methylene blue (proveblue) (1 trial)

miltefosine (impavido) (1 trial)

moxifloxacin (avelox) (1 trial)

mulberry leaf extract (1 trial)

norepinephrine (levophed) (1 trial)

omeprazole (prilosec) (1 trial)

oryza sativa (1 trial)

paromomycin (humatin) (1 trial)

phenylephrine (Prefrin) (1 trial)

pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)

progesterone (progestasert) (1 trial)

rabies immune globulin (human) (Kedrab) (1 trial)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (5 trials)

tacrolimus (prograf) (3 trials)

type-ii collagen (1 trial)

vasopressin (vasostrict) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Acquired Immunodeficiency Syndrome (Phase 3)

Acute Kidney Injury (Phase 3)

Alcohol Drinking (Phase 3)

Alcoholism (Phase 3)

Avitaminosis (Phase 4)

Basal Ganglia Diseases (Phase 4)

Birth Weight (Phase 3)

Brain Diseases (Phase 4)

Burns (Phase 3)

Calculi (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Central Nervous System Diseases (Phase 4)

Cerebral Infarction (Phase 3)

Chickenpox (Phase 4)

Cognition Disorders (Phase 4)

Coinfection (Phase 2)

Communicable Diseases (Phase 3)

Cross Infection (Phase 3)

Dilatation, Pathologic (Phase 4)

Disease (Phase 4)

Dry Eye Syndromes (Phase 4)

Duodenal Ulcer (Phase 3)

Dyspepsia (Phase 4)

Dystonia (Phase 4)

Dystonic Disorders (Phase 4)

Emergencies (Phase 4)

Endometriosis (Phase 4)

Enterocolitis (Phase 3)

Enterocolitis, Necrotizing (Phase 3)

Epilepsy (Phase 4)

Erectile Dysfunction (Phase 4)

Fibrosis (Phase 3)

Fractures, Bone (Phase 3)

Gallbladder Diseases (Phase 4)

Glomerulonephritis, IGA (Phase 4)

Heartburn (Phase 4)

Hemophilia A (Phase 4)

Hemorrhage (Phase 2)

Hepatitis (Phase 4)

Herpes Zoster (Phase 4)

Hip Fractures (Phase 3)

HIV Infections (Phase 4)

Hordeolum (Phase 3)

Hyperhomocysteinemia (Phase 4)

Hyperparathyroidism (Phase 4)

Hyperparathyroidism, Secondary (Phase 4)

Hypersensitivity (Phase 3)

Hypogonadism (Phase 4)

Hypokinesia (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 3)

Iridocyclitis (Phase 3)

Ischemia (Phase 3)

Keratoconjunctivitis Sicca (Phase 4)

Kidney Calculi (Phase 4)

Kidney Diseases (Phase 4)

Latent Tuberculosis (Phase 3)

Lupus Nephritis (Phase 4)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Mental Disorders (Phase 4)

Movement Disorders (Phase 4)

Nephritis (Phase 4)

Nephrolithiasis (Phase 4)

Nervous System Diseases (Phase 4)

Neurodegenerative Diseases (Phase 4)

Obstetric Labor, Premature (Phase 4)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 4)

Parkinsonian Disorders (Phase 4)

Pelvic Pain (Phase 4)

Peptic Ulcer (Phase 3)

Peritonitis (Phase 4)

Premature Birth (Phase 4)

Premenstrual Syndrome (Phase 4)

Psychotic Disorders (Phase 4)

Pterygium (Phase 3)

Rabies (Phase 4)

Respiratory Aspiration (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rickets (Phase 4)

Sepsis (Phase 3)

Shared Paranoid Disorder (Phase 4)

Shoulder Pain (Phase 2)

Stomach Ulcer (Phase 3)

Stroke (Phase 3)

Torticollis (Phase 4)

Toxemia (Phase 3)

Tuberculosis (Phase 3)

Ulcer (Phase 3)

Uterine Hemorrhage (Phase 2)

Uveitis (Phase 3)

Uveitis, Anterior (Phase 3)

Varicella Zoster Virus Infection (Phase 4)

Vitamin D Deficiency (Phase 4)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 135
  • # of Trial APIs: 165